400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2500101322
结束
/
/
/
2025-04-23
/
/
None
Promoting physical activity among primary school children and their families in Hong Kong: A community-based healthy lifestyle program ("F.I.T. Family")
Promoting physical activity among primary school children and their families in Hong Kong: A community-based healthy lifestyle program ("F.I.T. Family")
To examine the efficacy of a 4-month home-based lifestyle program ("F.I.T. Family") for primary school children and their families in local Hong Kong communities targeting 2018 Hong Kong Report Card indicators with poor grades (Physical Fitness, Family, and Obesity).
随机平行对照
其它
Following baseline measurements, block randomization will be applied to allocate family units to either "F.I.T. Family" intervention (FIT) or waitlist control (CON) in a 1:1 ratio. Randomization allocation software will be used to generate random block sizes. A sequentially numbered procedure will be applied.
Randomization and allocation will be operated by a trained research staff who is independent of the study and supervised by the Project Coordinator.
University Grants Committee Research Impact Fund
/
200
/
2023-01-01
2024-12-31
/
1. Parents (father or/and mother) with their primary school-aged children (6–12 years old); 2. local Chinese families being able to read and speak Cantonese.;
请登录查看1. chronic medical and health conditions, including but not limited to cardiovascular diseases, diabetes, neurological disease, musculoskeletal disorder, cancers, and autoimmune diseases; 2. severe high blood pressure (>= 180/100 mm Hg); 3. a history of myocardial infarction, uncompensated heart failure, or unstable angina pectoris; 4. any pre-existing medical or physical issues that could affect the experimental test and training, as suggested by the current exercise prescription guidelines.;
请登录查看Department of Sports Science and Physical Education, The Chinese University of Hong Kong
/
浙江道尔生物科技有限公司2026-04-16
新药创始人2026-04-16
丁香园 Insight 数据库2026-04-16
2021至2023年理赔服务2026-04-16
干细胞与外泌体2026-04-16
细胞与基因治疗领域2026-04-16
北京药研汇2026-04-16
正大天晴药业集团2026-04-16
复融生物2026-04-16
先通医药2026-04-16